The prognostic value of general laboratory testing in patients with COVID-19

Zhihua Lv1, Wei Wang2, Bin Qiao1

  • 1Department of Clinical Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Insights

Peripheral blood cell counts and biochemical markers aid in diagnosing COVID-19 and predicting patient outcomes. The neutrophil/lymphocyte ratio (NLR) shows high diagnostic accuracy for coronavirus disease 2019.

Area of Science:

  • Clinical Medicine
  • Hematology
  • Biochemistry

Background:

  • Peripheral blood lymphocyte count (LYM) and general biochemical markers are recognized for their diagnostic and prognostic value in COVID-19.
  • The utility of other indices in COVID-19 assessment remains less explored.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic value of peripheral blood cell counts and general biochemical markers in patients with COVID-19.
  • To identify key indicators for distinguishing COVID-19 severity and predicting adverse outcomes.

Main Methods:

  • A cohort of 94 COVID-19 patients was classified into moderate, severe, and critical groups.
  • Forty healthy individuals served as controls.
  • Peripheral blood cell counts and general biochemical analyses were performed and compared across groups.

Main Results:

  • Statistically significant differences (p < 0.01) were observed in peripheral blood analyses between COVID-19 patients and healthy controls.
  • Significant variations (p < 0.05) in LYM, neutrophil count (Neu), platelet count (PLT), and white blood cell count (WBC) were noted among different COVID-19 severity groups.
  • Key biochemical markers including direct bilirubin (DBIL), low-density lipoprotein cholesterol (LDL-Ch), and urea showed significant differences (p < 0.05) across severity levels.
  • The neutrophil/lymphocyte ratio (NLR) demonstrated high sensitivity and specificity for COVID-19 diagnosis.

Conclusions:

  • Peripheral blood cell counts and biochemical markers are valuable for diagnosing COVID-19 and predicting disease severity and patient prognosis.
  • Economical and readily accessible indices are recommended for clinical use in diagnosing and predicting COVID-19 outcomes.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
633
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
977
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
579
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
96
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
109
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
84